- Home
- MDIA vs CNTB Comparison
MDIA vs CNTB Comparison
Compare MDIA & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDIA
- CNTB
- Stock Information
- Founded
- MDIA 2019
- CNTB 2012
- Country
- MDIA United States
- CNTB United States
- Employees
- MDIA N/A
- CNTB N/A
- Industry
- MDIA Broadcasting
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- MDIA Consumer Discretionary
- CNTB Health Care
- Exchange
- MDIA Nasdaq
- CNTB Nasdaq
- Market Cap
- MDIA N/A
- CNTB 55.2M
- IPO Year
- MDIA N/A
- CNTB 2021
- Fundamental
- Price
- MDIA $1.17
- CNTB $0.69
- Analyst Decision
- MDIA
- CNTB Strong Buy
- Analyst Count
- MDIA 0
- CNTB 1
- Target Price
- MDIA N/A
- CNTB $8.00
- AVG Volume (30 Days)
- MDIA 9.7K
- CNTB 17.3K
- Earning Date
- MDIA 05-14-2025
- CNTB 03-31-2025
- Dividend Yield
- MDIA N/A
- CNTB N/A
- EPS Growth
- MDIA N/A
- CNTB N/A
- EPS
- MDIA N/A
- CNTB N/A
- Revenue
- MDIA $69,296,000.00
- CNTB $26,033,000.00
- Revenue This Year
- MDIA N/A
- CNTB $997.61
- Revenue Next Year
- MDIA N/A
- CNTB N/A
- P/E Ratio
- MDIA N/A
- CNTB N/A
- Revenue Growth
- MDIA 94.96
- CNTB N/A
- 52 Week Low
- MDIA $0.66
- CNTB $0.55
- 52 Week High
- MDIA $6.86
- CNTB $2.66
- Technical
- Relative Strength Index (RSI)
- MDIA 46.35
- CNTB 29.72
- Support Level
- MDIA $1.12
- CNTB $0.80
- Resistance Level
- MDIA $1.19
- CNTB $0.84
- Average True Range (ATR)
- MDIA 0.06
- CNTB 0.06
- MACD
- MDIA -0.00
- CNTB -0.01
- Stochastic Oscillator
- MDIA 35.20
- CNTB 0.30
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.